Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.005% for Epiphora
NCT07816224Phase 2Recruiting
- Start
- Sep 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Myopine in epiphora (2 arms). Primary endpoint: Change in tearing at 7 days. Started Sep 2026; status: recruiting.
02
Drugs
Myopine
03
Conditions
epiphora
Beyond the preview
Go deeper on NCT07816224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816224.